title: Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in pompe mice.
abstract: Clinical studies of enzyme replacement therapy for Pompe disease have indicated that relatively high doses of recombinant human acid alpha-glucosidase (rhGAA) may be required to reduce the abnormal glycogen storage in cardiac and skeletal muscles. This may be because of inefficient cation-independent mannose 6-phosphate receptor (CI-MPR)-mediated endocytosis of the enzyme by the affected target cells. To address this possibility, we examined whether the addition of a high affinity ligand to rhGAA would improve its delivery to these cells. Chemical conjugation of high mannose oligosaccharides harboring mono- and bisphosphorylated mannose 6-phosphates onto rhGAA (neo-rhGAA) significantly improved its uptake characteristics by muscle cells in vitro. Infusion of neo-rhGAA into Pompe mice also resulted in greater delivery of the enzyme to muscle tissues when compared with the unmodified enzyme. Importantly, this increase in enzyme levels was associated with significantly improved clearance of glycogen ( approximately 5-fold) from the affected tissues. These results suggest that CI-MPR-mediated endocytosis of rhGAA is an important pathway by which the enzyme is delivered to the affected lysosomes of Pompe muscle cells. Hence, the generation of rhGAA containing high affinity ligands for the CI-MPR represents a strategy by which the potency of rhGAA and therefore the clinical efficacy of enzyme replacement therapy for Pompe disease may be improved.
authors.affiliation: Genzyme Corporation, Framingham, Massachusetts 01701-9322, USA.
authors.forename: Yunxiang
authors.initials: Y
authors.lastname: Zhu
authors.forename: Xuemei
authors.initials: X
authors.lastname: Li
authors.forename: Josephine
authors.initials: J
authors.lastname: Kyazike
authors.forename: Qun
authors.initials: Q
authors.lastname: Zhou
authors.forename: Beth L
authors.initials: BL
authors.lastname: Thurberg
authors.forename: Nina
authors.initials: N
authors.lastname: Raben
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Mattaliano
authors.forename: Seng H
authors.initials: SH
authors.lastname: Cheng
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006003:Glycogen / Q000378:metabolism*; D006009:Glycogen Storage Disease Type II / Q000378:metabolism*; D008360:Mannosephosphates / Q000378:metabolism*; D051379:Mice; D009132:Muscles / Q000378:metabolism; D032446:Myoblasts / Q000378:metabolism; D009844:Oligosaccharides / Q000378:metabolism*; D021381:Protein Transport / Q000502:physiology; D000520:alpha-Glucosidases / Q000378:metabolism*
chemical_list: D008360:Mannosephosphates; D009844:Oligosaccharides; C027693:mannose-6-phosphate; D006003:Glycogen; D000520:alpha-Glucosidases